Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.42 |
| ▸ | NPC1 | O15118 | 3/20 | 0.42 |
| ▸ | RAB9A | P51151 | 3/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.42 |
| ▸ | TSHR | P16473 | 3/20 | 0.42 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.42 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.42 |
| ▸ | RELA | Q04206 | 1/20 | 0.42 |
| ▸ | ABCB1 | P08183 | 2/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.41 |
| ▸ | USP2 | O75604 | 1/20 | 0.41 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5726382 | 0.97 | ALDH1A1 (0.43) | ALDH1A1NPC1RAB9ASMN1; SMN2TSHR | |
| SCHEMBL5726292 | 0.86 | ALDH1A1 (0.43) | ALDH1A1NPC1RAB9ASMN1; SMN2TSHR | |
| SCHEMBL5727041 | 0.85 | ALDH1A1 (0.41) | ALDH1A1NPC1RAB9ASMN1; SMN2TSHR | |
| SCHEMBL5727370 | 0.84 | ALDH1A1 (0.43) | ALDH1A1NPC1RAB9ASMN1; SMN2TSHR | |
| SCHEMBL5726364 | 0.84 | ABCB1 (0.60) | ALDH1A1NPC1RAB9ASMN1; SMN2TSHR | |
| SCHEMBL5726488 | 0.81 | RAB9A (0.43) | ALDH1A1NPC1RAB9ASMN1; SMN2TSHR | |
| SCHEMBL5726586 | 0.81 | ALDH1A1 (0.45) | ALDH1A1NPC1RAB9ASMN1; SMN2TSHR | |
| SCHEMBL5726116 | 0.80 | ALDH1A1 (0.48) | ALDH1A1NPC1RAB9ASMN1; SMN2TSHR | |
| SCHEMBL5726230 | 0.77 | SMN1; SMN2 (0.43) | ALDH1A1NPC1RAB9ASMN1; SMN2TSHR | |
| SCHEMBL5726443 | 0.74 | ALDH1A1 (0.49) | ALDH1A1NPC1RAB9ASMN1; SMN2TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1395568-B1 | 4-AMINOPYRIMIDINE DERIVATIVES | HOFFMANN LA ROCHE (CH) | 2006-11-02 | — | — | EP | claimed |
| EP-1395568-A1 | 4-AMINOPYRIMIDINE DERIVATIVES | F. HOFFMANN-LA ROCHE AG (CH) | 2004-03-10 | — | — | EP | claimed |
| US-20030022907-A1 | 4-aminopyrimidine derivatives | HOFFMANN-LA ROCHE INC. | 2003-01-30 | — | — | US | claimed |
| WO-2002094795-A1 | 4-AMINOPYRIMIDINE DERIVATIVES | F. HOFFMANN-LA ROCHE AG (CH) | 2002-11-28 | — | — | WO | claimed |
| US-7138404-B2 | 4-aminopyrimidine derivatives | HOFFMANN-LA ROCHE INC. (US) | 2006-11-21 | — | — | US | disclosed |
| EP-1395568-B1 | 4-AMINOPYRIMIDINE DERIVATIVES | HOFFMANN LA ROCHE (CH) | 2006-11-02 | — | — | EP | disclosed |
| EP-1395568-A1 | 4-AMINOPYRIMIDINE DERIVATIVES | F. HOFFMANN-LA ROCHE AG (CH) | 2004-03-10 | — | — | EP | disclosed |
| US-20030022907-A1 | 4-aminopyrimidine derivatives | HOFFMANN-LA ROCHE INC. | 2003-01-30 | — | — | US | disclosed |
| WO-2002094795-A1 | 4-AMINOPYRIMIDINE DERIVATIVES | F. HOFFMANN-LA ROCHE AG (CH) | 2002-11-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030022907-A1 | 4-aminopyrimidine derivatives | GRM5, GRIK5, GRM1 | ALDH1A1 786/4885NPC1 1688/4885RAB9A 1679/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.